The Manila Times2d
GSK's Omjjara (momelotinib) approved in Singapore as the first treatment indicated for myelofibrosis patients with anaemia
Approval is for use in myelofibrosis patients with moderate to severe anaemia who are JAK-naive or previously treated with ...
Their flesh turns to bone, but a new treatment might help them
That is the predicament of patients with fibrodysplasia ossificans progressiva (FOP) or “Stone Man Syndrome”, a rare musculoskeletal condition where, after birth and progressively through life, ...
IFLScience25d
What Is Stone Man Disease?
IFLScience needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time.
Malaysian Reserve1y
GSK Canada’s submission for momelotinib for the treatment of myelofibrosis accepted for review by Health Canada
J Hematol Oncol. 2022;15(7):1-18. [18] Asshoff M, et al. Momelotinib inhibits ACVR1/ALK2, decreases hepcidin production, and ameliorates anemia of chronic disease in rodents. Blood.